Psilocybin mushroom or magic mushroom is the group of fungi that contains psilocybin component. Psilocybin activates serotonin receptors and creates visual and auditory hallucination. This affects mood, cognition, perception, sleep, hunger, body temperature. Magic mushroom can be taken with food, drinks, dry or raw. Psilocybin was isolated first by Dr. Albert Hofmann in 1958. But magic mushroom has been used in ancient religious rites and ceremonies. You can buy psilocybin Canada to get fresh magic mushrooms in your hands.
Magic mushroom or psilocybin is a hallucinogen drug which is similar to LSD and cause to see or hear sensations that are not real. This hallucinogen properties can be used to medicine therapy of depression, cluster headaches, anxiety disorders, end-stage cancer anxiety.
In October 1799, the first experiment took place in London investigating mushrooms and psychedelic effects by Dr. Everdad Brande.
Around the years of 1960 to 1977, the compound psilocybin was first studied as a psychotherapeutic drug. Research on humans in this field was approved by the Food and Drug Administration (FDA), but after a while it was ended and did not continue until the late 1990s, as researches on the medical use of psilocybin were finally picked up again. One can easily buy psilocybin Canada or even can mail order magic mushrooms Canada.
In 20th century, research programs found that a well careful monitored use of psilocybin can be beneficial to psychiatric disorders, spiritual development. Many researches are undergoing to evaluate the safety and efficiency of psilocybin for the treatment of cluster headache, depression, anxiety, obsessive-compulsive disorder, addiction to alcohol and other drugs, as well as neuroimaging experiments.
Journal of Psychopharmacology published two studies noting psilocybin can reverse the feeling of “existential distress” that patients feel after chemotherapy for cancer.
Near 2010-2011, New York University (NYU) Langone Medical Center in New York City and Johns Hopkins Medical School in Baltimore have completed another two studies about the effectiveness of psilocybin in treatment of cancer.
In New York University study, 29 advanced cancer patients were given either a single dose of psilocybin or vitamin B (niacin), both in conjunction with psychotherapy. For a cross-over study, seven weeks later, treatments were switched. In 60% to 80% of the patients who were given psilocybin, had a relief from rapid distress and lasted over six months. The long-term effect was evaluated by researchers looking at test scores for depression and anxiety.
In the Johns Hopkins medical school study, 51 adults with advanced cancer were treated with a small dose of psilocybin after five weeks they were given a higher dose, with a 6-month follow-up. Like the New York University study, about 80% of patients experienced significant relief from their anxiety and depression that lasted up to six months.
Still researchers have some questions about the safety and efficiency of psilocybin in medical use as it has some side effects.
US Drug Enforcement Agency (DEA) has listed psilocybin as Schedule I drug thus it is not available for medical use. U.S. Food and Drug Administration (FDA) may only be allow researchers to get access to the illegal compound for the study under special waivers. If DEA approve psilocybin for medical use it need to r classify as Schedule IV drug.